RESUMO
BACKGROUND: Cutaneous reactions, mostly on injection site after mRNA-based COVID-19 vaccines, have been reported but not with detailed histopathological characterization. OBJECTIVES: Characterization and classification of these reactions in a clinical and pathological point of view. METHODS: Monocentric case series of 11 patients with cutaneous manifestations, clinically and histologically characterized after COVID-19 vaccination. RESULTS: From January to June 2021, we recorded 11 cutaneous reactions to mRNA COVID-19 vaccines from BNT162b2 (n = 8) and mRNA-1273 (n = 3). Generalized reactions showing erythematous rash or purpura were the most common clinical presentation, and drug-reaction-like pattern was the most common histological finding. CONCLUSIONS: A proper clinicopathological classification will be helpful in the early diagnosis and management of the cutaneous reactions to mRNA COVID-19 vaccines.
Assuntos
Vacinas contra COVID-19 , COVID-19 , Vacina BNT162 , Humanos , RNA Mensageiro , SARS-CoV-2Assuntos
Líquen Plano , Piperidinas , Pirimidinas , Humanos , Pirimidinas/uso terapêutico , Pirimidinas/administração & dosagem , Piperidinas/uso terapêutico , Piperidinas/administração & dosagem , Líquen Plano/tratamento farmacológico , Inibidores de Proteínas Quinases/uso terapêutico , Inibidores de Proteínas Quinases/administração & dosagem , Feminino , Pirróis/uso terapêutico , Pirróis/administração & dosagem , Pessoa de Meia-Idade , Masculino , Administração Tópica , Administração CutâneaRESUMO
Cellulitis is an acute bacterial non-necrotizing dermal-hypodermal infection predominantly affecting the lower limbs. It is characterised by a circumscribed erythema with a raised border and fever. The predisposing factors are skin wounds, edema from any cause and systemic factors (diabetes, immunosuppression). The diagnosis is clinical and the most common complication is recurrence. Other complications include local abscess, fasciitis and bacteremia. The germ is rarely identified. The majority of infections (85%) is due to group A beta-hemolytic streptococcus. The treatment of cellulitis consists of an association of an antibiotic with rest of the concerned area.
Assuntos
Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/terapia , Erisipela/diagnóstico , Erisipela/terapia , Antibacterianos/uso terapêutico , Celulite (Flegmão)/epidemiologia , Celulite (Flegmão)/microbiologia , Erisipela/epidemiologia , Erisipela/microbiologia , Humanos , Recidiva , Prevenção Secundária/métodosRESUMO
Seborrhoeic dermatitis is a frequent chronic inflammatory dermatosis characterized by erythematous patches surmounted by fatty and yellowish scales, affecting particularly the scalp, the naso-labial folds and the eyebrows. Its etio-pathogeny is still not clear, but Malassezia type yeast appear to play a very important role in its development. Several conditions can be associated with high prevalency of seborrhoeic dermatitis (HIV, Parkinson's disease, Down's Syndrome). No curative treatment is available yet, but nevertheless the symptomatology can be controlled, mainly with topical treatments, and particularly antifungals. This article will develop first clinical and pathological aspects of the disease, then propose therapeutic recommendations based on evidences from the literature.